Sandbox carlos: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) mNo edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
Line 7: | Line 7: | ||
::* 1. '''Outpatient treatment''' | |||
::*1. Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection: | |||
:::* Preferred regimen:[[Macrolides]] (azithromycin, clarithromycin, or erythromycin) (strong recommendation) level I evidence | |||
==References== | ==References== | ||
{{reflist}} | {{reflist}} |
Revision as of 20:15, 14 July 2015
- Mycoplasma pneumoniae
Return to Top
-
- 1. Community-acquired pneumonia
- Preferred regimen: Macrolide OR Tetracycline
- Alternative regimen: Fluoroquinolone
- 1. Outpatient treatment
- 1. Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection:
- Preferred regimen:Macrolides (azithromycin, clarithromycin, or erythromycin) (strong recommendation) level I evidence
References
- ↑ Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC; et al. (2007). "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults". Clin Infect Dis. 44 Suppl 2: S27–72. doi:10.1086/511159. PMID 17278083.
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.